MedTrace Logo

NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study

NCT00708851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-04-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if combining a daily at-home regimen using an LCD Solution with a 3 times weekly outpatient narrowband UVB phototherapy regimen could be a safe, effective, rapid, and, convenient treatment for plaque psoriasis.

Conditions

Interventions

OTHER

LCD Solution with NB-UVB Phototherapy

LCD Solution: 2 applications / day NB-UVB Phototherapy: 3 light sessions / week

DEVICE

NB-UVB Light Device (311-315 nm)

NB-UVB Phototherapy: 3 light exposures / week

Sponsors & Collaborators

  • NeoStrata Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Jerry Bagel, MD · Windsor Dermatology, East Windsor, NJ 08520

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-01-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708851 on ClinicalTrials.gov